Speakers Adem Koksal Scientific Director, Biologics Drug Discovery Biogen Allan Jensen Vice President Lundbeck Aloïse Mabondzo Co-Founder CERES Brain Therapeutics Anu Bhattacharyya Executive Director Biology/Nucleotide Repeat Disorders PTC Therapeutics Bellos Hadjivassiliou Senior Principal Scientist Bristol Myers Squibb Bryn Martin Vice President of Research, Drug Delivery, and CSF Sciences Alcyone Therapeutics Cheng-Chia Wu Assistant Professor Columbia University Irving Medical Center Christopher Octeau Senior Scientist Capsida Darin Falk Chief Scientific Officer Lacerta Therapeutics Didier Lefebvre Research Fellow Abbvie Dr. William Loundon, MD, PhD VP NeuroScience Bionaut Felix Schumacher Program Leader Targeted Therapeutics Roche Fergus Quigley Director, Device Development Lead (Early Stage Development) Takeda Habib Baghirov Scientific Lead Roche Haiyan Peng Associate Director, Research Alnylam Pharmaceuticals Iosif Pediaditakis Associate Director, Neuroscience Alchemab Therapeutics Jeff Kurz Associate Director Alnylam Pharmaceuticals Kate Henry Senior Scientist in Gene Therapy Accelerator Unit Biogen Keri Kasun Associate Medical Director Biogen Leah Sabin Executive Director, Regeneron Genetic Medicines Regeneron Max Nowak Senior Scientist Viridian Therapeutics Nathalie Agar Associate Professor of Neurosurgery & of Radiology Harvard Medical School Niels Janssen Group Head DMPK/PD Roche Panna Sharma Chief Executive Officer, President & Board Member Lantern Pharma Patrick Wen Director Dana-Farber Cancer Institute Sabyasachi Dash Senior Scientist Alexion-AstraZeneca Rare Disease Shyam Ramachandran Senior Group Head, Neurologic Diseases Sanofi Smrithi Padmakumar Drug Product Development Senior Scientist Spark Therapeutics Stephan Mittermeyer Vice President, Therapeutic Strategies, CNS Gene Therapy AskBio Suganya Selvarajah Director - Biology Attralus William Elmquist Distinguished Professor, Department of Pharmaceutics University of Minnesota FULL EVENT GUIDE PRE-CONFERENCE WORSKHOP